Philip Morris CEO: We're pleased with FDA approval of Zyn
Jacek Olczak, Philip Morris International CEO, joins CNBC's 'Money Movers' to discuss the company's most recent earnings.
medtechdive9d
FDA webpages on clinical trial diversity removed after Trump orders
The website changes raise concerns about “the interference of politics with the study and the practice” of science and ...
Sensus Healthcare anticipates significant revenue from FDA agreements in H2 2025
Q4 2024 Management View Joe Sardano, Chairman and CEO, highlighted the company’s strong business momentum in 2024, driven by record sales of SRT-100 systems and the expansion of the Fair Deal ...
FiercePharma6d
Fierce Pharma Asia—Takeda's next CEO; Enhertu's novel FDA nod; East Asian American C-suite execs
Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim ...